| |
|
|
|
LA Jolla Pharma  
|
|
5.66 0.15 (0.03%) |
01-25 16:00 |
|
Open: |
5.48 |
Pre close: |
5.51 |
Target:
|
7.29
|
|
High: |
5.69 |
Low: |
5.31 |
Resistance:
|
6.24
7.29
|
|
Volume: |
371,973 |
Market Cap: |
155M |
Support:
|
4.71
3.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.51
 |
MACD |
MACD(12,26):
|
0.34 |
|
MA(20): |
4.68 |
Signal(12,26,9): |
0.21 |
|
MA(100): |
4.34 |
Stochastic Oscillator |
%K(14,3):
|
72.31 |
|
MA(250): |
5.09  |
%D(3): |
70.21 |
|
Average Volume(K) |
3-Month: |
91877
|
52-Week |
High:
|
9.38 |
|
10-Days: |
432968 |
Low: |
3.36 |
|
RSI |
RSI(14):
|
69.45 |
Change(%): |
-18.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.243 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.38 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-23.6 |
Shares Float (M) |
12.75 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.46 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
59.0 |
% Held by Institutions |
88.00 |
|
Forward EPS |
-7.850 |
Gross Profit (p.s.) |
0.755 |
Shares Short (K) |
2930 |
|
Book Value (p.s.) |
-3.270 |
EBITDA (p.s.) |
-1.501 |
P/E |
-2.52 |
|
Sales Per Share |
1.085 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.73 |
|
Profit Margin |
-205.85 |
Operating Cash Flow
(M) |
-47.49 |
P/S |
5.21 |
|
Operating Margin |
-145.93 |
Levered Free Cash Flow
(M) |
-28.32 |
P/CF |
-3.26 |
|
|
|
|
|
|
